While GnRH-ant protocols effectively prevent OHSS, they may be associated with a modest reduction in oocyte yield (~1.5 fewer oocytes per cycle compared with long-agonist protocols) [72,95]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.